The implications when offering percutaneous nephrostomy for the management of malignant obstructive uropathy secondary to urological malignancy: can we be more selective?

Osinibi, Elizabeth; Doan, Hong; Mercado-Campero, Alejandro; Abbaraju, Jayasimha; Masood, Shikohe; Madaan, Sanjeev

Osinibi, Elizabeth; Doan, Hong; Mercado-Campero, Alejandro; Abbaraju, Jayasimha; Masood, Shikohe; Madaan, Sanjeev.

Afiliación

Osinibi E; Darent Valley Hospital Medway Maritime Hospital, Darenth Wood Road, Dartford, DA2 8DA, UK.
Doan H; Medway Maritime Hospital, Gillingham, UK.
Mercado-Campero A; University College London Hospitals Campero NHS Foundation Trust, London, UK.
Abbaraju J; Darent Valley Hospital, Urology, Dartford, UK.
Masood S; Medway Maritime Hospital, Gillingham, UK.
Madaan S; Dartford and Gravesham NHS Trust, Dartford, UK.

Ther Adv Urol ; 15: 17562872231207729, 2023.

Article en En | MEDLINE | ID: mdl-37901283

Palabras clave

malignant obstruction; nephrostomy; obstructive nephropathy; obstructive uropathy; ureteric obstruction

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Ther Adv Urol Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google